Gonadotropin-releasing hormone agonist treatment and ischemic heart disease among female patients with breast cancer: A cohort study.
Yi-Sheng ChouChun-Chieh WangLi-Fei HsuPei-Hung ChuangChi-Feng ChengNai-Hsin LiChu-Chieh ChenChien-Liang ChenYun-Ju LaiYung-Feng YenPublished in: Cancer medicine (2022)
The study showed that the use of GnRH agonists for breast cancer treatment was significantly associated with a reduced risk of IHD. Further research is required to investigate the possible protective effect of GnRH on IHD.
Keyphrases